Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacotherapy and Intensive Treatment - 2
This study has been completed.
Study NCT00000218   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 20, 1999   Last Updated: March 23, 2009   History of Changes

September 20, 1999
March 23, 2009
 
 
  • Severity addiction
  • Depression
  • Depression, anxiety
Same as current
Complete list of historical versions of study NCT00000218 on ClinicalTrials.gov Archive Site
 
 
 
Pharmacotherapy and Intensive Treatment - 2
Pharmacotherapy and Intensive Treatment

The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.

 
Phase IV
Interventional
Treatment
  • Cocaine-Related Disorders
  • Substance-Related Disorders
Drug: Carbamazepine
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
353
June 2005
 

Please contact site for information.

Female
18 Years to 60 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00000218
 
NIDA-06954-2, R18-06954-2
National Institute on Drug Abuse (NIDA)
Department of Veterans Affairs
Principal Investigator: William Haning, M.D. University of Kansas
National Institute on Drug Abuse (NIDA)
March 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP